Experienced in Acute Lymphoblastic Leukemia (ALL)

Bernd M. Spriewald

Erlangen, BY, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Acute Lymphoblastic Leukemia (ALL)
Erlangen, BY, DE 
OverviewLocationsClinical Research

Overview

Bernd Spriewald practices in Erlangen, Germany. Mr. Spriewald is rated as an Experienced expert by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Common Cold, Acute Lymphoblastic Leukemia (ALL), Acute Kidney Failure, Kidney Transplant, and Bone Marrow Transplant.

His clinical research consists of co-authoring 61 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Acute Lymphoblastic Leukemia (ALL).

Gender
Male

Locations

Erlangen, BY, Germany
Other Locations
Mainz, RP, Germany
Alexander, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Autologous Transplantation After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell Lymphoma - a Randomized European Mcl Network Trial
Autologous Transplantation After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell Lymphoma - a Randomized European Mcl Network Trial
Enrollment Status: Recruiting
Publish Date: December 19, 2017
Intervention Type: Drug
Study Drugs: R-CHOP/R-DHAP, Ibrutinib (Induction), ASCT Conditioning, Ibrutinib (Maintenance)
Study Phase: Phase 3

61 Total Publications

Vaccination-induced T cell responses maintain polyclonality with high antigen receptor avidity.
Vaccination-induced T cell responses maintain polyclonality with high antigen receptor avidity.
Journal: Science immunology
Published: October 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Spriewald's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile